Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A De Man

Showing results (141-150 of 161) with videos related to

Pageof 17
Sort By:
European Journal of Internal Medicine|November 17, 2022
Time-trends in disease characteristics and comorbidities in patients with chronic hepatitis B in the period 1980-2020D P C van der Spek, W K Katwaroe, L A van Kleef, et al.
Digestive Surgery|February 23, 2008
Somatostatin receptor in human hepatocellular carcinomas: biological, patient and tumor characteristicsC Verhoef, H van Dekken, L J Hofland, et al.
Gut|February 14, 2003
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferaseA B van Nunen, B E Hansen, D J Suh, et al.
The Netherlands Journal of Medicine|May 24, 2007
Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a reviewK F Kok, P J Wahab, R H J Houwen, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2011
The long-term outcome of patients with polycystic liver disease treated with lanreotideM Chrispijn, F Nevens, T J G Gevers, et al.
Journal of Hepatology|July 14, 2001
Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantationN V Naoumov, A R Lopes, P Burra, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
Hepatitis B immunoglobulins inhibit dendritic cells and T cells and protect against acute rejection after liver transplantationJ Kwekkeboom, T Tha-In, W M W Tra, et al.
Journal of Viral Hepatitis|August 20, 2005
Flow cytometry of fine-needle-aspiration biopsies: a new method to monitor the intrahepatic immunological environment in chronic viral hepatitisD Sprengers, R G van der Molen, J G Kusters, et al.
Journal of Hepatology|May 24, 2003
Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonrespondersEugene R Schiff, Jules L Dienstag, Selim Karayalcin, et al.
Journal of Viral Hepatitis|May 26, 2017
Prediction of long-term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE-B scoreW P Brouwer, A J P van der Meer, A Boonstra, et al.
Pageof 17

Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
European Journal of Internal Medicine|November 17, 2022
Time-trends in disease characteristics and comorbidities in patients with chronic hepatitis B in the period 1980-2020D P C van der Spek, W K Katwaroe, L A van Kleef, et al.
Digestive Surgery|February 23, 2008
Somatostatin receptor in human hepatocellular carcinomas: biological, patient and tumor characteristicsC Verhoef, H van Dekken, L J Hofland, et al.
Gut|February 14, 2003
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferaseA B van Nunen, B E Hansen, D J Suh, et al.
The Netherlands Journal of Medicine|May 24, 2007
Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a reviewK F Kok, P J Wahab, R H J Houwen, et al.
Alimentary Pharmacology & Therapeutics|November 25, 2011
The long-term outcome of patients with polycystic liver disease treated with lanreotideM Chrispijn, F Nevens, T J G Gevers, et al.
Journal of Hepatology|July 14, 2001
Randomized trial of lamivudine versus hepatitis B immunoglobulin for long-term prophylaxis of hepatitis B recurrence after liver transplantationN V Naoumov, A R Lopes, P Burra, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2005
Hepatitis B immunoglobulins inhibit dendritic cells and T cells and protect against acute rejection after liver transplantationJ Kwekkeboom, T Tha-In, W M W Tra, et al.
Journal of Viral Hepatitis|August 20, 2005
Flow cytometry of fine-needle-aspiration biopsies: a new method to monitor the intrahepatic immunological environment in chronic viral hepatitisD Sprengers, R G van der Molen, J G Kusters, et al.
Journal of Hepatology|May 24, 2003
Lamivudine and 24 weeks of lamivudine/interferon combination therapy for hepatitis B e antigen-positive chronic hepatitis B in interferon nonrespondersEugene R Schiff, Jules L Dienstag, Selim Karayalcin, et al.
Journal of Viral Hepatitis|May 26, 2017
Prediction of long-term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE-B scoreW P Brouwer, A J P van der Meer, A Boonstra, et al.
Pageof 17